| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |